Clinical Trial Update: Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety of HPN (Hyperion)-100 for long-term treatment of urea cycle disorders has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• HPN (Hyperion)-100

Snippet

Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-08-15